The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
KABRADG Key Metrics
KABRADG Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
KABRADG Share Price
KABRADG
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
KABRADG Stock Analysis
Views
Red Flags
Positive
Not enough talking point with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Neutral
Not enough talking point with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.474511.
Snapshot
See detailed analysis
KABRADG Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
KABRADG Bulk, Block & Insider Trades
KABRADG Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Kabra Drugs Limited is engaged in the business of permaculture manufacturing and trading in pharma-related products. The Company is also involved in the trading and marketing of biological Active Pharmaceutical Ingredients (API’s) and biochemical. It offers drugs for cardiovascular disease, gastroen... Read More
Key personnel
Mr. T. Pavanasam
Chief Financial Officer
Ms. Monika Nishant Lal Sanwal
Compliance Officer, Company Secretary
Mr. N. AravindD
Managing Director, Executive Director
Mr. Kuniamuthur Nanjappan AnandD
Executive Director
Ms. A. AnithaD
Additional Non-Executive Independent Director
Mr. Bharat DewdaD
Additional Independent Non-Executive Director
Mr. Arvind HirveD
Additional Independent Non-Executive Director
Ms. Nikita SinhaD
Additional Independent Non-Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Kabra Drugs Ltd.?
The current share price of Kabra Drugs Ltd. is ₹ 27.99 as of 09 Jan 2026.
What is the PE ratio of Kabra Drugs Ltd.?
The Price-to-Earnings (PE) ratio of Kabra Drugs Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Kabra Drugs Ltd.?
Kabra Drugs Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the market cap of Kabra Drugs Ltd.?
The market capitalization of Kabra Drugs Ltd. stands at ₹ 66.36 Cr.
What is the dividend yield of Kabra Drugs Ltd.?
The dividend yield of Kabra Drugs Ltd. is - based on the current market price.
What is the RSI of Kabra Drugs Ltd.?
The Relative Strength Index (RSI) of Kabra Drugs Ltd. is 47.81.
What is the FII and DII holding in Kabra Drugs Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Kabra Drugs Ltd. shares.
What sector does Kabra Drugs Ltd. belong to?
Kabra Drugs Ltd. operates in the Healthcare sector.
What is the beta of Kabra Drugs Ltd. stock?
The beta of Kabra Drugs Ltd. stock is -0.02, indicating its volatility relative to the broader market.